X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (31) 31
hygiene (31) 31
medical or veterinary science (31) 31
preparations for medical, dental, or toilet purposes (31) 31
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
tumors (6) 6
humans (5) 5
receptor, epidermal growth factor - genetics (4) 4
research (4) 4
tyrosine kinase (4) 4
acquired-resistance (3) 3
agriculture (3) 3
animal husbandry (3) 3
breast cancer (3) 3
cancer (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
care of birds, fishes, insects (3) 3
cell lung-cancer (3) 3
drug resistance, neoplasm - genetics (3) 3
erlotinib (3) 3
fishing (3) 3
forestry (3) 3
hunting (3) 3
index medicus (3) 3
investigating or analysing materials by determining theirchemical or physical properties (3) 3
lung cancer (3) 3
lung neoplasms - genetics (3) 3
measuring (3) 3
metastasis (3) 3
multidisciplinary sciences (3) 3
new breeds of animals (3) 3
physics (3) 3
rearing or breeding animals, not otherwise provided for (3) 3
testing (3) 3
trapping (3) 3
angiogenesis (2) 2
animals (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis (2) 2
biological sciences (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
cell proliferation - drug effects (2) 2
cells (2) 2
chemistry (2) 2
drug resistance (2) 2
erlotinib hydrochloride (2) 2
gefitinib (2) 2
gene expression (2) 2
genetic aspects (2) 2
health aspects (2) 2
imatinib resistance (2) 2
immunoblotting (2) 2
lung neoplasms - drug therapy (2) 2
lungs (2) 2
metallurgy (2) 2
mice (2) 2
molecular sequence data (2) 2
mutation - genetics (2) 2
oncology (2) 2
organic chemistry (2) 2
peptides (2) 2
phosphorylation (2) 2
phosphorylation - drug effects (2) 2
protein kinase inhibitors - pharmacology (2) 2
protein kinase inhibitors - therapeutic use (2) 2
quinolines - pharmacology (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
receptors (2) 2
respiratory tract diseases (2) 2
sensitivity (2) 2
therapy (2) 2
abl gene mutation (1) 1
activation (1) 1
acute lymphoblastic-leukemia (1) 1
alleles (1) 1
amino acid sequence (1) 1
aminoquinolines (1) 1
amplification (1) 1
aniline compounds (1) 1
antineoplastic agents - therapeutic use (1) 1
apoptosis regulatory proteins - chemistry (1) 1
apoptosis regulatory proteins - metabolism (1) 1
apoptotic proteins (1) 1
article (1) 1
base sequence (1) 1
bcr-abl (1) 1
beer (1) 1
binding (1) 1
biochemistry (1) 1
breast neoplasms - blood supply (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - pathology (1) 1
breasts (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
cell line, tumor (1) 1
cell lines (1) 1
cell motility (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37) 37
French (9) 9
German (5) 5
Chinese (3) 3
Spanish (3) 3
Portuguese (2) 2
Danish (1) 1
Greek (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 12/2005, Volume 37, Issue 12, pp. 1315 - 1316
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2005, Volume 102, Issue 21, pp. 7665 - 7670
Non-small cell lung cancers (NSCLCs) with activating mutations in the kinase domain of the epidermal growth factor receptor (EGFR) demonstrate dramatic, but... 
Biological Sciences | Receptors | Drug trafficking | Internalization | Liver | Cell lines | Lesions | Codons | Genetic mutation | Tumors | Resistance mechanisms | Molecular targeted therapy | Drug resistance | Tyrosine kinase inhibitor | Non-small cell lung cancer | non-small cell lung cancer | APOPTOSIS | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | TUMORS | CELL LUNG-CANCER | THERAPY | molecular targeted therapy | drug resistance | tyrosine kinase inhibitor | MUTATIONS | IMATINIB RESISTANCE | ERLOTINIB | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Aniline Compounds | Humans | Lung Neoplasms - metabolism | Molecular Sequence Data | Immunoblotting | Quinolines - pharmacology | Receptor, ErbB-2 - physiology | Quinazolines - metabolism | Base Sequence | Organic Chemicals - pharmacology | Phosphorylation - drug effects | Tumor Cells, Cultured | Receptor, Epidermal Growth Factor - physiology | Lung Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Mutation - genetics | Sequence Analysis, DNA | Drug Resistance - genetics | Signal Transduction - drug effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Neoplasm Recurrence, Local - genetics | Signal Transduction - physiology | Cell Proliferation - drug effects | Aminoquinolines | Lung cancer | Research
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 01/2010, Volume 107, Issue 3, p. 1100
  The mechanisms underlying tumoral secretion of signaling molecules into the microenvironment, which modulates tumor cell fate, angiogenesis, invasion, and... 
Genotype & phenotype | Lungs | Breast cancer | Metastasis | Gene expression | Cells | Tumors
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2010, Volume 107, Issue 3, pp. 1100 - 1105
The mechanisms underlying tumoral secretion of signaling molecules into the microenvironment, which modulates tumor cell fate, angiogenesis, invasion, and... 
Cell motility | Angiogenesis | Receptors | Lungs | Epithelial cells | Breasts | Breast cancer | Metastasis | Tumors | Cancer
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 04/2008, Volume 7, Issue 4, p. 874
Patients with non–small cell lung cancer (NSCLC) harboring activating mutations in the epidermal growth factor receptor ( EGFR ) kinase domain tend to respond... 
irreversible kinase inhibitors | drug resistance | EGFR T790M
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 04/2008, Volume 7, Issue 4, pp. 874 - 879
Patients with non-small cell lung cancer (NSCLC) harboring activating mutations in the epidermal growth factor receptor (EGFR) kinase domain tend to respond... 
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 05/2005, Volume 102, Issue 21, p. 7665
  Non-small cell lung cancers (NSCLCs) with activating mutations in the kinase domain of the epidermal growth factor receptor (EGFR) demonstrate dramatic, but... 
Signaling | Lung cancer | Mutation | Tumors
Journal Article
2004
In this thesis, the regulation of ASPP1 and ASPP2 was investigated. ASPP1 and ASPP2 are p53 co-activators that can specifically induce p53 dependent apoptosis... 
Dissertation
11/2018
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
08/2018
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
10/2016
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
10/2015
Η παρούσα εφεύρεση κατευθύνεται σε μεθόδους για την θεραπεία του καρκίνου με αντίσταση στην γεφιτινίβη και/ή ερλοτινίβη. Ένα άτομο με καρκίνο ελέγχεται για... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
06/2014
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for... 
HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
01/2013
The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.